2008, Number 2
<< Back Next >>
Rev Salud Publica Nutr 2008; 9 (2)
Biopéptidos alimenticios: nuevos promotores de la salud
Chel-Guerrero L, Betancur-Ancona D
Language: Spanish
References: 26
Page:
PDF size: 85.72 Kb.
ABSTRACT
Today, the food science had promoted a novel nutrition concept which includes same functional foods to exert a major health and to disappear of disease risks on human body. For this reason, the important foods companies like Danone®, Nestlé®, Poleva®, have a bioactive and nutritive compound into their products, from animal and vegetable raw materials. These foods can offer these beneficial aspects for health. So, this is an important aspect of food industries which had begun the research and development of these bioactive compounds from natural raw materials which there are high protein content; these raw material foods can serve to extract these bioactive peptides with physiological effect on health. The bioactive peptides usually contain 2 to 20 amino acid residues per molecule and they are inactive within the original protein, but once released, function as regulatory compounds with hormone-like activity that is based on the inherent amino acid composition and sequence. These peptides can be liberated from the parent protein during gastrointestinal digestion in the body or during food processing like enzymatic hydrolysis. The demonstrated beneficial effects of the bioactive peptides (antihypertensive, antimicrobial, inmmunomodulatory, mineral binding, opiate, antioxidant, antithrombotic and other activity) had made to inclusion on them like compound on functional food formulations for to affect beneficially one or more target functions in the body; the objective is clear, it is to look at improved state of health and well-being and/or reduction of risk of disease and even an improvement in the quality of life.
REFERENCES
Burdock, G.A., I.G. Carabin and J.C. Griffiths 2006. The importance of GRAS to the functional food and nutraceutical industries. Toxicology. 221; 17-27
Dávila, A.M., E. Sangronis y M. Granito 2003. Leguminosas germinadas o fermentadas: alimentos o ingredientes de alimentos funcionales. Archivos Latinoamericanos de Nutrición. 53 (4): 348-354
Korhonen, H. 2002. Technology options for new nutritional concepts. International Journal of Dairy Technology, 55 (2): 79-88
Secretaría de Salud de México 2005. Estadísticas de mortalidad en México: muertes registradas en el año 2003. Salud Pública de México 47 (2): 171-187
Bovet, P. 2002. The cardiovascular disease epidemic: global, regional, local. Tropical Medicine and International Health, 7(9): 717–721
WHO 2005. Statistical information system: Numbers and rates of registered deaths. The World Health: Reducing Risks, Promoting Healthy Life. Ginebra, pp 13-15.
Pellegrini, A. 2003. Antimicrobial peptides from food proteins. Current Pharmaceutical Design. 9: 1225-1238.
Meisel, H. and W. Bockemann 1999. Bioactive peptides encrypted in milk poteins: proteolytic activation and thropho-functional properties. Antonie van Leeuwenhoek, 76: 207-215.
Baró, L., J. Jiménez, A. Martínez-Férez y J.J. Bouza 2001. Péptidos y proteínas de la leche con propiedades funcionales. Ars. Pharmaceutica. 42(3-4):135-145.
Wang, W. and E. Gonzalez de Mejía 2005. A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Comprehensive Reviews in Food Science and Food Safety, 4: 63-78.
Vioque, J. y F. Millán 2005. Los péptidos bioactivos en alimentación: nuevos agentes promotores de salud. Agro CSIC. 26: 103-107.
Van der Ven, C., H. Gruppen, A. B. D. De Bont and J. G. A. Voragen 2002. Correlations between biochemical characteristics and foam-forming and stabilizing ability of whey and casein hydrolysates. Journal of Agricultural and Food Chemistry, 50: 2938-2946.
Gobbetti, M., F. Minervini and C. Grizzelo 2004. Angiotensin I converting-enzime-inhibitory and antimicrobial bioactive peptides. International Journal of Dairy Technology. 57 (2/3): 173-188.
Fiat, A. M., D. Migliore-Samour, P. Jollés, L. Ruet and J. Caen. 1993. Biologically Active Peptides from Milk Proteins with Emphasis on Two Examples Concerning Antithrombotic and Immunomodulating Activities. Journal of Dairy Science, 76(1): 301-310.
Jauhiainen, T., R. Korpela, and A. Mäyrä-Mäkinen 2002. VALIO: Information about the Evolus® fermented milk. Printed by Lars Eriksen. Finland, pp 1-15.
Diplock, A. T., P. J. Agget, M. Ashwell, F. Bornet, E. B. Fern and M. B. Roberfroid 1999. Scientific concepts of functional foods in Europe: consensus document. British Journal of Nutrition, 81(suppl.): S1-S27.
Bellisle, F.; AK Diplock, G Hornstra, B Koletzko, M Roberfroid, S Salminen and WHM Saris 1998. Functional Food Science in Europe. British Journal of Nutrition, 80: S1-S193.
Hasler, C. M. 1998. Functional Foods: Their Role in Disease Prevention and Health Promotion. Food Technology, 52(11): 63-70.
Vioque, J. y F. Millan. Op. cit..
Jauhiainen, T. et al, Op. cit
Hata, Y., M. Yamamoto, M. OhnI, K. Nakajima, Y. Nakamura and Y. Takano, 1996. A placebo controlled study of the effect of a sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition, 64: 767-777.
Escovar, X and JG Chalela 2004. Péptidos antimicrobianos Cutáneos. Dermatología Peruana, 14(1): 40-43.